Evaluation of TTI-0102 versus placebo in MELAS patients
The main criteria for participation The clinical trial is recruiting 12 patients aged 16 to… Read More »Evaluation of TTI-0102 versus placebo in MELAS patients
The main criteria for participation The clinical trial is recruiting 12 patients aged 16 to… Read More »Evaluation of TTI-0102 versus placebo in MELAS patients
The main criteria for participation This international trial is recruiting, particularly in France, patients of… Read More »Expanded access to doxecitin and doxribtimine (MT-1621)
The main criteria for participation The study is recruiting, in several countries around the world… Read More »Natural history study in autosomal dominant optic atrophy (OPA1 gene)
The main criteria for participation The MitoID study is recruiting 30 participants monitored at the… Read More »Immune Dysfunctions and Mitochondrial Diseases (MitoID)
The main criteria for participation The UNIFAI study is recruiting 3,000 participants of all ages… Read More »Natural History Study of the UNIFIED Friedreich’s Ataxia (UNIFAI) Global Clinical Consortium
The main criteria for participation The PROFA study is recruiting 200 patients aged 12 and… Read More »Economic and psychosocial impacts of the disease reported by patients with Friedreich’s ataxia (PROFA)
The main criteria for participation The MétabOCT study is recruiting people aged 18 to 60… Read More »Metabolomic analyses as a function of retinal nerve fiber layer thickness in patients with NOHL-associated mutations (MetabOCT)
The main criteria for participation The TELE-MIT study is recruiting 15 adults with mitochondrial disease… Read More »Adapted physical activity and video consultation in mitochondrial diseases: study of efficacy and tolerance (TELE-MIT)
The main criteria for participation The FALCON trial is recruiting 180 adults in several countries… Read More »Efficacy of KL 1333 in adult patients with primary mitochondrial disease (FALCON)